Saturday, October 08, 2011

Crestor Lawsuit

Originally developed by the Japanese pharmaceutical company Shionogi to help people at risk for heart disease maintain cardiovascular health, Crestor was subsequently licensed to Astra-Zeneca in 1998. In 2003, Crestor was approved for use in the U.S. by the FDA. Crestor works to reduce "bad" cholesterol in the body and help raise "good" cholesterol.

A member of the cholesterol-lowering drugs known as "statins", Crestor's approval had some limitations to use due to some known potential side effects when taken by certain at risk people. In 2009 the FDA scrutinized the advertising Astra-Zeneca used for Crestor due to some misleading safety claims that were in the advertising. I would assume that the misleading information was an oversight by the creators of the advertising, since I can not see Astra-Zeneca doing something such as that and opening themselves up to the possibility of having to face a Crestor lawsuit by people the company desired to help because of injury resulting from misleading advertising.

It is a lesson that any major company should learn - to pay strict attention to any and all advertising to assure that no misleading claims about their products are made that could open them up to some kind of lawsuit later on.

This has been a sponsored post